• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Income growth was driven by a rise in formulation exports by 105.2 pc

Advertisement

Ahmedabad Jan. 22 For the third quarter ended December 31, 2006, the net profit of the Ahmedabad-based pharma company, Cadila Healthcare Ltd (Zydus Cadila) surged by 66.4 per cent to Rs 65.9 crore, up from Rs 39.6 crore in the same period last year on a consolidated basis, the company said here on Monday.

The total income for the same period was up 28.7 per cent at Rs 492 crore. Its profit before depreciation interest in tax was up 31.2 per cent to Rs 101.9 crore during the quarter from Rs 77.7 crore in the corresponding period last year. The income growth was mainly driven by a growth of 105.2 per cent in formulation exports, whereas the company's active pharmaceutical ingredients exports were up 45 per cent, it said in a release here.

Better performance

During the quarter, the company's subsidiaries in France and the US registered better performance. Zydus France SAS, which currently markets 85 generic presentations registered 188.3 per cent growth in sales for the quarter. In the US, the company posted sales of Rs 38.6 crore during the quarter.

Related Stories:
Zydus net up 36% at Rs 39.6 cr

More Stories on : Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Nava Bharat Ventures Q3 net profit up at Rs 36.45 cr

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line